Cargando…
Subtype of SCLC Is an Intrinsic and Persistent Feature Through Systemic Treatment
INTRODUCTION: SCLC is an aggressive malignancy with poor outcome. Most patients have disease recurrence despite treatments with multiple modalities. Subtyping of SCLC has been proposed recently, and novel agents targeting specific subtypes are actively being investigated. In this study, we evaluated...
| Autores principales: | , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Elsevier
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10507151/ https://www.ncbi.nlm.nih.gov/pubmed/37731627 http://dx.doi.org/10.1016/j.jtocrr.2023.100561 |